Pharmaceutical Pricing

₹8,447 Crore in Medicine Overcharging Claims Remain Outstanding

India has ₹8,447.4 crore in outstanding medicine overcharging claims, according to figures from the National Pharmaceutical Pricing Authority as of March 31, 2026. The Supreme Court has also questioned whether trade-margin restrictions introduced for anti-cancer medicines should be extended to other medicines and medical products.